8-K//Current report
Ambrx Biopharma Inc. 8-K
Accession 0001193125-23-253527
CIK 0001836056operating
Filed
Oct 9, 8:00 PM ET
Accepted
Oct 10, 4:49 PM ET
Size
225.2 KB
Accession
0001193125-23-253527
Documents
- 8-Kd514763d8k.htmPrimary
8-K
- EX-101.SCHamam-20231010.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.DEFamam-20231010_def.xml
XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
- EX-101.LABamam-20231010_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PREamam-20231010_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLd514763d8k_htm.xml
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001193125-23-253527-xbrl.zip
IDEA: XBRL DOCUMENT
Issuer
Ambrx Biopharma Cayman, Inc.
CIK 0001836056
Entity typeoperating
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001836056
Filing Metadata
- Form type
- 8-K
- Filed
- Oct 9, 8:00 PM ET
- Accepted
- Oct 10, 4:49 PM ET
- Size
- 225.2 KB